Use of ezetimibe during HIV infection

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 1, 2009, Pages 218-220

  Stebbing, J ^a   Asghar, A K ^a   Holmes, P ^a   Bower, M ^a   Isenman, H L ^a   Nelson, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cholesterol; Ezetimibe; HIV; Study

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SIMVASTATIN; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MONOTHERAPY; NAUSEA; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; HIV INFECTIONS; HUMANS; HYPERCHOLESTEROLEMIA; TREATMENT OUTCOME;

EID: 57649228970     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn440     Document Type: Letter

References (8)

1. Kastelein JJ, Akdim F, Stroes ES et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43.
2. Brown BG, Taylor AJ. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 2008; 358: 1504-7.
3. Drazen JM, Jarcho JA, Morrissey S et al. Cholesterol lowering and ezetimibe. N Engl J Med 2008; 358:1507-8.
4. Rossebo AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-56.
5. Peto R, Emberson J, Landray M et al. Analyses of cancer data from three ezetimibe trials. N Engl J Med 2008; 359: 1357-66.
6. Coll B, Aragones G, Parra S et al. Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients. AIDS 2006; 20: 1675-7.
7. Negredo E, Molto J, Puig J et al. Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins. AIDS 2006; 20: 2159-64.
8. Berg-Wolf MV, Klibanov OM, Gaughan JP et al. Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients. AIDS Patient Care STDS 2008; 22: 483-8.